Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Advent International poised to take control of another drugmaker
Private equity firm Advent International is set to strike its second deal within a year for a controlling stake in ......
Healthcare
Morgan Stanley PE moves to exit another healthcare portfolio firm
Morgan Stanley Private Equity Asia has decided to exit an Indian healthcare portfolio company as transactions in the sector pick...
Healthcare
Value Lens: Gland Pharma may be cheaper than global firms but hovers above locals
The proposed initial public offering of Gland Pharma Ltd values the maker of injectable drugs at a premium to locally ......
Healthcare
Healthcare PE deals climb in April-June, M&As maintain pace
The number of private equity deals in India’s healthcare sector rose in the April-June period to their highest level in...
Healthcare
Troubled US pharma firm Akorn selling stalled India business
US-based generics company Akorn, Inc., which earlier this year filed for protection from creditors under American bankruptcy law,...
Healthcare
After buyout by KKR, JB Chemicals snaps up local firm's pharma business
JB Chemicals & Pharmaceuticals Ltd, in which global private equity giant KKR is set to acquire a controlling stake, has ......
Healthcare
How IPO-bound Gland Pharma's valuation spiked under China's Fosun
China’s Shanghai Fosun Pharmaceutical Group, which acquired a majority stake in Gland Pharma Ltd less than three years ago,...
Healthcare
Quadria founders' healthcare VC fund eyes much bigger corpus for second vehicle
Healthcare-focused venture capital firm Healthquad Advisors Pvt. Ltd is planning a second outing that could be almost six times...
Finance
Bank of Baroda, other lenders count cost of loans in NMC Health collapse
As the crisis engulfing his business empire deepened, Bavaguthu Raghuram Shetty met with Bank of Baroda officials in mid-March...
Healthcare
Value Lens: Piramal Pharma stake comes at some discount but may almost lose that tag
Private equity firm Carlyle has agreed to buy a fifth of Piramal Enterprises Ltd’s pharmaceutical business at some discount...
